Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights
- On Track to Report Initial Clinical Data from pheEDIT PKU Gene Editing Trial Mid-Year 2023 - - First Presentations of Preclinical Data with GTx-mAb Development Candidate HMI-104 for PNH, and... | May 11, 2023
United States Cara Mayfield Albert Seymour Slattery Jr Oxford Biomedica American Society Of Gene Cell Therapy
Source: marketscreener.com